Coriolis

Coriolis Pharma operates on a global scale as a contract research organization (CRO) and leads in the research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines. Established in 2008, Coriolis specializes in early and late-stage biopharmaceutical development of liquid and freeze-dried drug products, encompassing freeze-drying process advancement and analytical technique development within R&D and GMP. The service portfolio is complemented by non-GMP manufacturing services for a diverse array of products.